(Q84751091)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21836610%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21836610%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21836610%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

K Mihara

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21836610%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

J Bhattacharyya

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21836610%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

A Kitanaka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21836610%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

K Yanagihara

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21836610%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Y Takei

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21836610%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

H Asaoku

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21836610%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Y Takihara

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21836610%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

A Kimura

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21836610%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

publication date

12 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21836610%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21836610%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21836610%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21836610%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

365-367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21836610%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2011.205

10 February 2020

exact match

0 references

cites work

Human CD38: a (r)evolutionary story of enzymes and receptors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.205

7 January 2021

Activated T-cell-mediated immunotherapy with a chimeric receptor against CD38 in B-cell non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.205

7 January 2021

Therapy of human B-cell lymphoma bearing SCID mice is more effective with anti-CD19- and anti-CD38-saporin immunotoxins used in combination than with either immunotoxin used alone

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.205

7 January 2021

Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.205

7 January 2021